Doximity is trading at $31.13, up +4.04%, with no clear company-specific catalyst identified for October 15, 2026.
- The Aledade Clinical AI integration appeared in company materials as previously announced, not new news explaining the move.
- Broader software shares were under pressure, so sector weakness does not explain Doximity’s gain.
- No reliable volume information was available.